Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

PJ Online | News: New antifungal for oesophageal candidiasis

Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 270 No 7244 p507
12 April 2003

This article

News summary

Related websites
Vicuron Pharmaceuticals (more)

New antifungal for oesophageal candidiasis

An antifungal agent in development, anidulafungin, is as effective as fluconazole in the treatment of oesophageal candidiasis, new data show. Anidulafungin, which is being developed by Vicuron Pharmaceuticals, belongs to a class of antifungals known as echinocandins.

The company says that, in preclinical studies, anidulafungin has been shown to destroy more than 99 per cent of candida, including fluconazole-resistant strains.

In a phase III trial, researchers randomly assigned around 600 patients to receive one of two regimens: anidulafungin 100mg intravenously plus oral placebo on day one followed by anidulafungin 50mg intravenously plus oral placebo daily for 14 to 21 days; or fluconazole 200mg orally with intravenous placebo on day one followed by fluconazole 100mg with intravenous placebo daily for 14 to 21 days.

Oesophageal candidiasis was cleared in 97.2 per cent of patients treated with anidulafungin (n=249) and in 98.8 per cent of patients treated with fluconazole (n=255). However, a higher relapse rate occurred in patients treated with anidulafungin than in those treated with fluconazole.

Vicuron Pharmaceuticals plans to file for a licence in the United Kingdom, as part of European approval, during the second half of this year.

Back to Top

Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal

Citation: The Pharmaceutical Journal URI: 20009206

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Paediatric Drug Handling

    Paediatric Drug Handling

    Written for new pharmaceutical scientists, this book provides a background in paediatric pharmacy and a comprehensive introduction to children's medication.

    £33.00Buy now
  • Foundation in Pharmacy Practice

    Foundation in Pharmacy Practice

    A practical and succinct overview of the principal pharmacy practice topics, for new pharmacy students.

    £33.00Buy now
  • Non-medical Prescribing

    Non-medical Prescribing

    An essential new guide designed to ensure confident prescribing in specialist areas.

    £27.00Buy now
  • Dale and Appelbe's Pharmacy and Medicines Law

    Dale and Appelbe's Pharmacy and Medicines Law

    This new edition of Dale and Appelbe's Pharmacy and Medicines Law is the definitive guide to law and ethics for pharmacy practice in the UK. It covers law and professional regulation and is firmly established as the definitive student textbook and reference work on this subject in the UK. Fully updated to include changes to pharmacy laws and regulation.

    £57.00Buy now
  • Print
  • Share
  • Comment
  • Rate
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.